3 completed, 2 active not recruiting. 3 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Active not recruiting 2, Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow Jetema Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of JTM104 Injection vs. Juvederm in Treating Moderate to Severe Nasolabial Folds JTM104, Juvederm® ULTRA PLUS XC - Nasolabial Folds, Wrinkles | Not applicable | Active not recruiting | Jetema Co., Ltd. | 100 | 2026-01-21 | 2026-07-27 |
| Clinical Investigation for Evaluating the Safety and Efficacy of JTM102 to Mid Face Volume Deficiency JTM102, Juvederm VOLUMA with Lidocaine - Mid Face Volume Deficit | Not applicable | Active not recruiting | Jetema Co., Ltd. | 149 | 2024-10-22 | 2026-07-24 |
| Phase 1 Trial of JTM201 in Subjects With Post-stroke Upper Limb Spasticity JTM201 in normal saline, BOTOX 100U in normal saline - Upper Limb Spasticity Post-Stroke | Phase 1 | Completed | Jetema Co., Ltd. | 30 | 2023-06-29 | 2025-12-18 |
| Evaluate the Post-marketing Efficacy and Safety of Eptq S and Eptq Lidocaine S Hyaluronic Acid (HA) - Nasolabial Folds, Mid Face Volume Loss | Completed | Jetema Co., Ltd. | 238 | 2022-09-21 | 2024-11-21 | |
| A Clinical Study to Evaluate the Efficacy and Safety of the Injection With UNIVELO Sub-Q, as Compared to Restylane® Sub-Q, in the Temporary Correction of the Nasolabial Fold UNIVELO Sub-Q 2mL, Restylane Sub-Q 2mL - Nasolabial Fold | Not applicable | Completed | Jetema Co., Ltd. | 65 | 2016-02-23 | 2025-09-08 |
Botulinum Toxins, Type A (1) · Saline Solution (1)
South Korea (4)